Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02366156 · ClinicalTrials.gov registry record · NA
A 12 Week, 3-Period Study to Evaluate the Effects of a Dietary Supplement on Lipid Metabolism
A NA study, sponsored by Access Business Group.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT02366156: Completed NA study, sponsored by Access Business Group.
NCT02366156 is a NA study that has completed, run by Access Business Group. The registered enrollment target is 93 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02366156, a NA study, has completed, sponsored by Access Business Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
This study will evaluate the effects of encapsulated botanical extracts, previously shown to inhibit the enzyme diacylglycerol-acyltransferase-1 (DGAT-1) in vitro, on fasting and postprandial lipid metabolism during an oral fat tolerance test (OFTT) in apparently healthy, overweight and obese adult men and women.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Low Dose Grape Blend
- DIETARY_SUPPLEMENT High Dose Grape Blend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02366156
The ClinicalTrials.gov registry entry for NCT02366156 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Access Business Group, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02366156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02366156 about?
NCT02366156 is a clinical study titled "A 12 Week, 3-Period Study to Evaluate the Effects of a Dietary Supplement on Lipid Metabolism". This study will evaluate the effects of encapsulated botanical extracts, previously shown to inhibit the enzyme diacylglycerol-acyltransferase-1 (DGAT-1) in vitro, on fasting and postprandial lipid metabolism during an oral fat tolerance test (OFTT) in apparently healthy, overweight and obese adult ...
What is the current status of trial NCT02366156?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2014-07. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02366156?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Low Dose Grape Blend (DIETARY_SUPPLEMENT), High Dose Grape Blend (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02366156?
This trial is sponsored by Access Business Group, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.